News | December 29, 2022
AIIMS organises consultation on ‘C2IQ’
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
New data from Boehringer Ingelheim support the potential use of nintedanib in children and adolescents with fibrosing interstitial lung disease
Indonesia national agency for drug and food control, BPOM, approved QDENGA for use in individuals 6 to 45 years of age
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
Xofluza is the first and only single-dose oral medicine for the treatment of influenza to be approved in the US for children as young as five years of age
Glenmark is the first company in India to market the innovative FDC of Indacaterol
If approved, Tafinlar + Mekinist may offer a potential new standard-of-care for pediatric patients with this brain cancer
Subscribe To Our Newsletter & Stay Updated
